In large corporations, systems and departments can be activated to solve problems. In a startup, founders must possess the courage and skills to solve problems themselves, as there are no established support systems to fall back on. You become the entire mechanism.

The initial period of struggle and repeated failures, while painful, is what forges a resilient team and a strong, frugal company culture. These early hardships create shared experiences that define the company's DNA for years to come.

Anthropic's efficiency culture was a direct result of early fundraising struggles, which forced them to define priorities and operate with discipline. In contrast, AI labs that raise massive rounds too easily miss this crucial, character-building phase. They lack the hardship needed to form a resilient culture, making them brittle.

Enara Bio's culture isn't a vague feeling; it's a structured system called the "Enara Expedition." This framework, built on pillars like autonomy and authenticity and values like courage and humility, acts as a "secret weapon." It provides the resilience needed to navigate scientific setbacks and challenging market conditions.

Lacking capital, Derek Small was forced to personally write grants and lead regulatory affairs. This hands-on, "virtual company" approach, born of necessity, gave him a profound, holistic understanding of the science and operations he wouldn't have gained otherwise.

Operating in emerging markets forces leaders to become scrappy "builders" who solve problems directly without waiting for additional headcount or resources. This bias for action and self-sufficiency, born from necessity and the lack of a 'cavalry to call,' is a valuable cultural asset when brought into more resource-rich U.S. corporate environments.

The biotech landscape in Southeast Asia has strong scientific talent but lacks a mature 'translation ecosystem' (VCs, experienced operators). Founders must take on the dual role of building their company and simultaneously cultivating the surrounding infrastructure, including talent, partnerships, and public trust.

Kainova's CEO describes how navigating multiple financial crises built "scar tissue" within his team. This resilience means they don't get paralyzed by adversity and maintain focus on execution, whether the company has $500 million or $500,000 in the bank. This experience is a key cultural strength.

Michal Preminger reflects that her former company, located outside a major biotech hub, had to invent solutions in isolation. It lacked the mentorship and deep market and business wisdom that permeates ecosystems like Boston, which would have accelerated its progress.